# PPOX

## Overview
The PPOX gene encodes the enzyme protoporphyrinogen oxidase, which plays a critical role in the heme biosynthesis pathway. This enzyme is categorized as a flavoprotein due to its requirement for flavin adenine dinucleotide (FAD) as a cofactor. Protoporphyrinogen oxidase catalyzes the oxidation of protoporphyrinogen IX to protoporphyrin IX, a precursor to heme, which is essential for various biological functions, including oxygen transport and electron transfer. The enzyme is located on the cytosolic side of the inner mitochondrial membrane and functions as a homodimer. Mutations in the PPOX gene can lead to variegate porphyria, a disorder characterized by photosensitivity and neurovisceral symptoms, due to the accumulation of porphyrin precursors (von2003Mitochondrial; Dailey1996Human).

## Structure
The human protoporphyrinogen oxidase (PPOX) enzyme is crucial in the biosynthesis of heme and chlorophyll. Its structure includes several key features that facilitate its function. The primary structure of PPOX consists of a sequence of amino acids forming a polypeptide chain. The secondary structure is characterized by the presence of alpha helices and beta sheets, which contribute to the enzyme's stability and function (Corradi2006Crystal).

The tertiary structure of PPOX is a three-dimensional conformation stabilized by interactions such as hydrogen bonds. This structure includes a hydrophobic cavity at the active site, which is crucial for substrate binding. The active site is defined by key residues, including Arg-95 and Gly-167, which are important for substrate interaction and are conserved across species (Corradi2006Crystal).

PPOX may form a homodimer, indicating a quaternary structure, although discrepancies exist between its dimerization state in solution and in crystal form (Corradi2006Crystal). The enzyme contains FAD-binding domains, which are essential for its catalytic activity. Post-translational modifications such as phosphorylation may occur, contributing to the enzyme's regulation and function. Splice variant isoforms of PPOX can result in structural and functional diversity, allowing the enzyme to adapt to different cellular conditions.

## Function
Protoporphyrinogen oxidase (PPOX) is a crucial enzyme in the heme biosynthesis pathway, catalyzing the oxidation of protoporphyrinogen IX to protoporphyrin IX, a precursor to heme. This reaction is essential for the production of heme, which is a vital component of hemoglobin, myoglobin, and various cytochromes involved in oxygen transport and electron transfer (Dailey1996Human; Ferreira1988Organization). PPOX is located on the cytosolic side of the inner mitochondrial membrane, where it functions as a homodimer with one noncovalently bound flavin adenine dinucleotide (FAD) per subunit (MORGAN2004Identification; Dailey2013Erythroid).

The enzyme's activity is oxygen-dependent and involves a six-electron oxidation process, which is critical for the conversion of protoporphyrinogen IX to protoporphyrin IX (von2003Mitochondrial; Maneli2003Kinetic). PPOX is synthesized in the cytoplasm and translocated to the mitochondria, facilitated by specific mitochondrial targeting sequences (MORGAN2004Identification; Dailey2013Erythroid). Proper functioning of PPOX is essential for maintaining adequate heme levels, which are necessary for various cellular functions, including respiration and detoxification (Novakova2021Heterologous). Deficiencies or mutations in the PPOX gene can lead to disorders such as variegate porphyria, characterized by photosensitivity and neurovisceral symptoms (von2003Mitochondrial; Dailey1996Human).

## Clinical Significance
Mutations in the PPOX gene are associated with variegate porphyria (VP), an autosomal dominant disorder characterized by a partial deficiency of the enzyme protoporphyrinogen oxidase, which is crucial in the heme biosynthetic pathway. This deficiency leads to the accumulation of porphyrins, resulting in clinical manifestations such as skin sensitivity to sunlight, blistering, and neuropsychiatric symptoms like severe abdominal pain and motor neuropathy (VafaeeShahi2022A; Barbaro2013Partial). 

The clinical presentation of VP is variable, with some patients experiencing acute attacks, cutaneous lesions, or both. The variability in symptoms can be attributed to different mutations in the PPOX gene, which include missense, nonsense, frameshift, and splice-site mutations (Méndez2011Functional; Whatley1999Variegate). These mutations often result in reduced enzyme activity, affecting heme production and leading to the disease (Méndez2011Functional; von2001Expression).

Genetic heterogeneity is notable in VP, with numerous mutations identified across different populations. For instance, studies have identified novel mutations specific to certain families or regions, highlighting the importance of genetic testing for accurate diagnosis and management (von2001Expression; Whatley1999Variegate).

## Interactions
Protoporphyrinogen oxidase (PPOX) is involved in several protein interactions within the mitochondrial heme biosynthesis pathway. It is primarily located on the mitochondrial matrix side of the inner membrane and forms part of a complex with other enzymes involved in heme synthesis. PPOX interacts with ferrochelatase (FECH), facilitating the transfer of protoporphyrin within the mitochondria. This interaction is crucial for the heme biosynthetic pathway, as it suggests a coordinated transfer of substrates between these enzymes (Medlock2015Identification).

PPOX is also part of a larger mitochondrial heme metabolism complex that includes aminolevulinic acid synthase-2 (ALAS2), ABCB10, ABCB7, and SUCLA2. These interactions are thought to facilitate substrate channeling and protect the cell from reactive intermediates. The study suggests that these interactions may be dynamic and dependent on the conformational states of the enzymes involved (Medlock2015Identification).

Additionally, PPOX is identified as a homodimer, which is essential for its function in heme synthesis. The presence of high molecular weight complexes containing PPOX and FECH indicates the involvement of additional proteins, suggesting a complex network of interactions within the mitochondrial matrix (Medlock2015Identification).


## References


[1. (von2003Mitochondrial) Mikael von und zu Fraunberg, Tommi Nyrönen, and Raili Kauppinen. Mitochondrial targeting of normal and mutant protoporphyrinogen oxidase. Journal of Biological Chemistry, 278(15):13376–13381, April 2003. URL: http://dx.doi.org/10.1074/JBC.M300151200, doi:10.1074/jbc.m300151200. This article has 18 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/JBC.M300151200)

[2. (VafaeeShahi2022A) Mohammad Vafaee-Shahi, Saeide Ghasemi, Aina Riahi, and Zahra Sadr. A boy with blistering of sun-exposed skin and finger shortening: the first case of variegate porphyria with a novel mutation in protoporphyrinogen oxidase (ppox) gene in iran: a case report and literature review. Italian Journal of Pediatrics, February 2022. URL: http://dx.doi.org/10.1186/s13052-022-01215-8, doi:10.1186/s13052-022-01215-8. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13052-022-01215-8)

[3. (Corradi2006Crystal) Hazel R. Corradi, Anne V. Corrigall, Ester Boix, C.Gopi Mohan, Edward D. Sturrock, Peter N. Meissner, and K.Ravi Acharya. Crystal structure of protoporphyrinogen oxidase from myxococcus xanthus and its complex with the inhibitor acifluorfen. Journal of Biological Chemistry, 281(50):38625–38633, December 2006. URL: http://dx.doi.org/10.1074/jbc.m606640200, doi:10.1074/jbc.m606640200. This article has 59 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m606640200)

[4. (Dailey2013Erythroid) H. A. Dailey and P. N. Meissner. Erythroid heme biosynthesis and its disorders. Cold Spring Harbor Perspectives in Medicine, 3(4):a011676–a011676, March 2013. URL: http://dx.doi.org/10.1101/cshperspect.a011676, doi:10.1101/cshperspect.a011676. This article has 93 citations and is from a peer-reviewed journal.](https://doi.org/10.1101/cshperspect.a011676)

[5. (Barbaro2013Partial) Michela Barbaro, Maire Kotajärvi, Pauline Harper, and Ylva Floderus. Partial protoporphyrinogen oxidase (ppox) gene deletions, due to different alu-mediated mechanisms, identified by mlpa analysis in patients with variegate porphyria. Orphanet Journal of Rare Diseases, January 2013. URL: http://dx.doi.org/10.1186/1750-1172-8-13, doi:10.1186/1750-1172-8-13. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1750-1172-8-13)

[6. (Méndez2011Functional) Manuel Méndez, Barbara X. Granata, María J. Morán Jiménez, Victoria E. Parera, Alcira Batlle, Rafael Enríquez de Salamanca, and María V. Rossetti. Functional Characterization of Five Protoporphyrinogen oxidase Missense Mutations Found in Argentinean Variegate Porphyria Patients, pages 91–97. Springer Berlin Heidelberg, 2011. URL: http://dx.doi.org/10.1007/8904_2011_77, doi:10.1007/8904_2011_77. This article has 4 citations.](https://doi.org/10.1007/8904_2011_77)

[7. (MORGAN2004Identification) Rhian R. MORGAN, Rachel ERRINGTON, and George H. ELDER. Identification of sequences required for the import of human protoporphyrinogen oxidase to mitochondria. Biochemical Journal, 377(2):281–287, January 2004. URL: http://dx.doi.org/10.1042/bj20030978, doi:10.1042/bj20030978. This article has 14 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj20030978)

[8. (Dailey1996Human) Tamara A. Dailey and Harry A. Dailey. Human protoporphyrinogen oxidase: expression, purification, and characterization of the cloned enzyme. Protein Science, 5(1):98–105, January 1996. URL: http://dx.doi.org/10.1002/pro.5560050112, doi:10.1002/pro.5560050112. This article has 86 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/pro.5560050112)

[9. (Medlock2015Identification) Amy E. Medlock, Mesafint T. Shiferaw, Jason R. Marcero, Ajay A. Vashisht, James A. Wohlschlegel, John D. Phillips, and Harry A. Dailey. Identification of the mitochondrial heme metabolism complex. PLOS ONE, 10(8):e0135896, August 2015. URL: http://dx.doi.org/10.1371/journal.pone.0135896, doi:10.1371/journal.pone.0135896. This article has 93 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0135896)

[10. (von2001Expression) Mikael von und zu Fraunberg, Raimo Tenhunen, and Raili Kauppinen. Expression and characterization of six mutations in the protoporphyrinogen oxidase gene among finnish variegate porphyria patients. Molecular Medicine, 7(5):320–328, May 2001. URL: http://dx.doi.org/10.1007/BF03402215, doi:10.1007/bf03402215. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/BF03402215)

[11. (Maneli2003Kinetic) Mbulelo H. Maneli, Anne V. Corrigall, Horst H. Klump, Lester M. Davids, Ralph E. Kirsch, and Peter N. Meissner. Kinetic and physical characterisation of recombinant wild-type and mutant human protoporphyrinogen oxidases. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 1650(1–2):10–21, August 2003. URL: http://dx.doi.org/10.1016/s1570-9639(03)00186-9, doi:10.1016/s1570-9639(03)00186-9. This article has 26 citations.](https://doi.org/10.1016/s1570-9639(03)00186-9)

[12. (Novakova2021Heterologous) Zora Novakova, Daria Khuntsaria, Marketa Gresova, Jana Mikesova, Barbora Havlinova, Shivam Shukla, Lucie Kolarova, Katerina Vesela, Pavel Martasek, and Cyril Barinka. Heterologous expression and purification of recombinant human protoporphyrinogen oxidase ix: a comparative study. PLOS ONE, 16(11):e0259837, November 2021. URL: http://dx.doi.org/10.1371/journal.pone.0259837, doi:10.1371/journal.pone.0259837. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0259837)

[13. (Ferreira1988Organization) G C Ferreira, T L Andrew, S W Karr, and H A Dailey. Organization of the terminal two enzymes of the heme biosynthetic pathway. orientation of protoporphyrinogen oxidase and evidence for a membrane complex. Journal of Biological Chemistry, 263(8):3835–3839, March 1988. URL: http://dx.doi.org/10.1016/s0021-9258(18)69000-3, doi:10.1016/s0021-9258(18)69000-3. This article has 102 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/s0021-9258(18)69000-3)

[14. (Whatley1999Variegate) Sharon D. Whatley, Hervé Puy, Rhian R. Morgan, Anne-Marie Robreau, Andrew G. Roberts, Yves Nordmann, George H. Elder, and Jean-Charles Deybach. Variegate porphyria in western europe: identification of ppox gene mutations in 104 families, extent of allelic heterogeneity, and absence of correlation between phenotype and type of mutation. The American Journal of Human Genetics, 65(4):984–994, October 1999. URL: http://dx.doi.org/10.1086/302586, doi:10.1086/302586. This article has 86 citations.](https://doi.org/10.1086/302586)